vs
Side-by-side financial comparison of Cerence Inc. (CRNC) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
Cerence Inc. is the larger business by last-quarter revenue ($115.1M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, Cerence Inc. posted the faster year-over-year revenue change (126.1% vs 27.7%). Cerence Inc. produced more free cash flow last quarter ($35.6M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 30.3%).
Cerence Inc. is an American multinational software company that develops artificial intelligence (AI) assistant technology primarily for automobiles.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CRNC vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $115.1M | $75.5M |
| Net Profit | $-5.2M | — |
| Gross Margin | 86.3% | 69.3% |
| Operating Margin | 25.5% | 22.7% |
| Net Margin | -4.6% | — |
| Revenue YoY | 126.1% | 27.7% |
| Net Profit YoY | 78.4% | — |
| EPS (diluted) | $-0.12 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $115.1M | $75.5M | ||
| Q3 25 | $60.6M | $54.5M | ||
| Q2 25 | $62.2M | $52.4M | ||
| Q1 25 | $78.0M | $46.0M | ||
| Q4 24 | $50.9M | $59.1M | ||
| Q3 24 | $54.8M | $80.5M | ||
| Q2 24 | $70.5M | $47.1M | ||
| Q1 24 | $67.8M | $43.8M |
| Q4 25 | $-5.2M | — | ||
| Q3 25 | $-13.4M | $8.8M | ||
| Q2 25 | $-2.7M | $5.9M | ||
| Q1 25 | $21.7M | $3.0M | ||
| Q4 24 | $-24.3M | — | ||
| Q3 24 | $-20.4M | $20.3M | ||
| Q2 24 | $-313.5M | $-4.5M | ||
| Q1 24 | $-278.0M | $-4.8M |
| Q4 25 | 86.3% | 69.3% | ||
| Q3 25 | 72.6% | 77.7% | ||
| Q2 25 | 73.7% | 76.5% | ||
| Q1 25 | 77.1% | 77.1% | ||
| Q4 24 | 65.0% | 76.4% | ||
| Q3 24 | 63.7% | 63.9% | ||
| Q2 24 | 71.5% | 77.4% | ||
| Q1 24 | 69.2% | 75.5% |
| Q4 25 | 25.5% | 22.7% | ||
| Q3 25 | -2.9% | 17.6% | ||
| Q2 25 | -1.5% | 12.7% | ||
| Q1 25 | 22.2% | 8.7% | ||
| Q4 24 | -33.3% | 22.6% | ||
| Q3 24 | -35.1% | 27.4% | ||
| Q2 24 | -503.1% | -4.6% | ||
| Q1 24 | -389.8% | -5.3% |
| Q4 25 | -4.6% | — | ||
| Q3 25 | -22.0% | 16.2% | ||
| Q2 25 | -4.4% | 11.2% | ||
| Q1 25 | 27.8% | 6.5% | ||
| Q4 24 | -47.7% | — | ||
| Q3 24 | -37.3% | 25.2% | ||
| Q2 24 | -444.5% | -9.6% | ||
| Q1 24 | -409.8% | -11.0% |
| Q4 25 | $-0.12 | $0.26 | ||
| Q3 25 | $-0.26 | $0.17 | ||
| Q2 25 | $-0.06 | $0.12 | ||
| Q1 25 | $0.46 | $0.06 | ||
| Q4 24 | $-0.57 | $0.40 | ||
| Q3 24 | $-0.49 | $0.41 | ||
| Q2 24 | $-7.50 | $-0.09 | ||
| Q1 24 | $-6.66 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | $97.5M |
| Total DebtLower is stronger | $171.9M | $22.7M |
| Stockholders' EquityBook value | $150.4M | $130.3M |
| Total Assets | $602.0M | $216.3M |
| Debt / EquityLower = less leverage | 1.14× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.5M | $97.5M | ||
| Q3 25 | $3.4M | $94.4M | ||
| Q2 25 | $5.5M | $96.0M | ||
| Q1 25 | $5.4M | $93.2M | ||
| Q4 24 | $3.9M | $101.0M | ||
| Q3 24 | $5.5M | $96.7M | ||
| Q2 24 | $5.4M | $96.8M | ||
| Q1 24 | $9.4M | $107.2M |
| Q4 25 | $171.9M | $22.7M | ||
| Q3 25 | $199.7M | $34.0M | ||
| Q2 25 | $198.8M | $45.3M | ||
| Q1 25 | $257.6M | $56.7M | ||
| Q4 24 | $256.2M | $68.0M | ||
| Q3 24 | $281.9M | $79.3M | ||
| Q2 24 | $280.4M | $90.7M | ||
| Q1 24 | $278.9M | $102.0M |
| Q4 25 | $150.4M | $130.3M | ||
| Q3 25 | $150.7M | $115.3M | ||
| Q2 25 | $155.7M | $104.7M | ||
| Q1 25 | $149.3M | $97.1M | ||
| Q4 24 | $120.7M | $92.1M | ||
| Q3 24 | $141.1M | $71.1M | ||
| Q2 24 | $154.2M | $48.5M | ||
| Q1 24 | $463.4M | $51.0M |
| Q4 25 | $602.0M | $216.3M | ||
| Q3 25 | $630.6M | $202.9M | ||
| Q2 25 | $636.8M | $194.9M | ||
| Q1 25 | $665.5M | $196.2M | ||
| Q4 24 | $617.5M | $213.3M | ||
| Q3 24 | $702.4M | $220.7M | ||
| Q2 24 | $674.0M | $205.0M | ||
| Q1 24 | $987.1M | $214.1M |
| Q4 25 | 1.14× | 0.17× | ||
| Q3 25 | 1.33× | 0.30× | ||
| Q2 25 | 1.28× | 0.43× | ||
| Q1 25 | 1.73× | 0.58× | ||
| Q4 24 | 2.12× | 0.74× | ||
| Q3 24 | 2.00× | 1.12× | ||
| Q2 24 | 1.82× | 1.87× | ||
| Q1 24 | 0.60× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.9M | $14.4M |
| Free Cash FlowOCF − Capex | $35.6M | $14.4M |
| FCF MarginFCF / Revenue | 31.0% | 19.1% |
| Capex IntensityCapex / Revenue | 2.0% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $74.6M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.9M | $14.4M | ||
| Q3 25 | $12.8M | $9.7M | ||
| Q2 25 | $23.7M | $14.1M | ||
| Q1 25 | $15.5M | $3.6M | ||
| Q4 24 | $9.3M | $15.6M | ||
| Q3 24 | $6.1M | $11.0M | ||
| Q2 24 | $12.9M | $1.0M | ||
| Q1 24 | $1.0M | $11.2M |
| Q4 25 | $35.6M | $14.4M | ||
| Q3 25 | $9.7M | $9.7M | ||
| Q2 25 | $16.1M | $14.1M | ||
| Q1 25 | $13.1M | $3.6M | ||
| Q4 24 | $7.9M | $15.6M | ||
| Q3 24 | $4.7M | $11.0M | ||
| Q2 24 | $12.1M | $1.0M | ||
| Q1 24 | $-801.0K | — |
| Q4 25 | 31.0% | 19.1% | ||
| Q3 25 | 16.1% | 17.7% | ||
| Q2 25 | 25.8% | 26.8% | ||
| Q1 25 | 16.8% | 7.7% | ||
| Q4 24 | 15.5% | 26.4% | ||
| Q3 24 | 8.5% | 13.7% | ||
| Q2 24 | 17.1% | 2.1% | ||
| Q1 24 | -1.2% | — |
| Q4 25 | 2.0% | 0.0% | ||
| Q3 25 | 5.0% | 0.0% | ||
| Q2 25 | 12.3% | 0.0% | ||
| Q1 25 | 3.0% | 0.1% | ||
| Q4 24 | 2.7% | 0.0% | ||
| Q3 24 | 2.6% | 0.0% | ||
| Q2 24 | 1.1% | 0.0% | ||
| Q1 24 | 2.7% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 0.71× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRNC
| License | $87.8M | 76% |
| Connected Services | $14.5M | 13% |
| Professional Services | $12.8M | 11% |
PBYI
Segment breakdown not available.
